Dendritic cell vaccines for high-grade gliomas

Glioblastoma (GBM) is the most common and fatal primary adult brain tumor. To date, various promising chemotherapeutic regimens have been trialed for use in GBM; however, temozolomide (TMZ) therapy remains the only US Food and Drug Administration-approved first-line chemotherapeutic option for newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Eagles, Matthew E, Nassiri, Farshad, Badhiwala, Jetan H, Suppiah, Suganth, Almenawer, Saleh A, Zadeh, Gelareh, Aldape, Kenneth D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067774/
https://www.ncbi.nlm.nih.gov/pubmed/30100728
http://dx.doi.org/10.2147/TCRM.S135865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067774/
https://www.ncbi.nlm.nih.gov/pubmed/30100728
http://dx.doi.org/10.2147/TCRM.S135865

Ejemplares similares